Does GUSELKUMAB Cause Therapy interrupted? 187 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 187 reports of Therapy interrupted have been filed in association with GUSELKUMAB (TREMFYA). This represents 0.7% of all adverse event reports for GUSELKUMAB.
187
Reports of Therapy interrupted with GUSELKUMAB
0.7%
of all GUSELKUMAB reports
0
Deaths
23
Hospitalizations
How Dangerous Is Therapy interrupted From GUSELKUMAB?
Of the 187 reports, 23 (12.3%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GUSELKUMAB. However, 187 reports have been filed with the FAERS database.
What Other Side Effects Does GUSELKUMAB Cause?
Product dose omission issue (9,267)
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which GUSELKUMAB Alternatives Have Lower Therapy interrupted Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE